In a meta-analysis of the pan-carcinoma resources and expression characteristics of 18,000 human tumors, Gentles et al. [60] found that KLRB1 is the most favorable pan-cancer prognosis gene and is a marker for enhanced innate immune characteristics in different T cell subsets. This evidence concerns the gene KLRB1 and cancer.